Another Refugee Tests Positive for Crimean Congo Fever in Kyangwali

Reading Time: 2 minutes

Another person has tested positive for Crimean Congo Hemorrhagic fever in kikuube district. The second victim is a 13-year-old boy who is also a refugee and resident of Musiinsa A Village in the Kyangwali Refugee settlement area.

Dr Nicholas Kwikiriza, the Kikuube District Health officer-DHO told Uganda Radio Network in an interview on Tuesday that the second victim, a contact of the first one, has already been admitted at the Kasonga Ebola Treatment Unit where he is getting treatment.

The first case of the disease in the district was reported on April 28, 2021. The victim was a 16-year old girl, a refugee and resident of Musiinsa A Village in the Kyangwali Refugee settlement area. The victim was first rushed to Kagoma Health Center II on April 27, 2021, within the settlement area with a high fever. She also had a severe headache, fatigue, abdominal pain, joint pain, vomiting blood and bleeding from the nose.

Her blood samples were immediately drawn and taken to Uganda Virus Research Institute in Entebbe from where she tested positive for Crimean Congo Haemorrhagic fever on April 28, 2021, and later  transferred from Kagoma Health Center II to Kasonga Ebola Treatment Unit where she is currently undergoing treatment. 

According to Dr Kwikiriza, currently, they have intensified their surveillance network within the settlement area as they continue to trace for more contacts.    

The virus, caused by a tick-borne virus, is primarily transmitted to people from ticks and livestock animals, while human-to-human transmission occurs from close contact with the blood, secretion, organs or other bodily fluids of infected persons. It has a case fatality rate of up to 40 per cent.

Uganda has had multiple Crimean-Congo haemorrhagic fever outbreaks since 2013 when the first outbreak was confirmed in the country. Tick exposure has been identified as the major risk factor according to studies done during various outbreaks in Uganda.       


Sponsored Articles